目的 分析注射用丹參多酚酸對腦梗死患者的臨床療效。方法 選取黑龍江省第二醫(yī)院40例腦梗死患者，隨機分為觀察組和對照組，對照組給予常規(guī)治療，觀察組在對照組治療基礎(chǔ)上加用注射用丹參多酚酸100 mg，1次/d靜滴，療程14d。比較兩組患者神經(jīng)功能改善情況及兩組患者治療有效率。結(jié)果 觀察組及對照組治療前NIHSS評分比較無明顯差異；治療后，觀察組及對照組NIHSS評分均低于治療前，同組治療前后比較差異有統(tǒng)計學(xué)意義（P<0.05）；治療后觀察組NIHSS評分低于對照組，兩者比較有顯著差異（P<0.05）。觀察組治療總有效率高于對照組，差異具有統(tǒng)計學(xué)意義（P<0.05）。結(jié)論 腦梗死患者早期應(yīng)用丹參多酚酸可有效改善神經(jīng)功能，具有良好療效。

Objective To analyze the clinical effect of salvianolate on patients with cerebral infarction. Methods Forty patients with cerebral infarction in our hospital were selected and randomly divided into observation group and control group. On the basis of conventional treatment,salvianolate was added to the observation group by injection. The improvement of neurological function and therapeutic efficiency were compared between the two groups. Results There was no significant difference in NHISS scores between the observation group and the control group before treatment. After treatment, the NIHSS score of the observation group was lower than that of the control group, and the difference was statistically significant (P<0.05). The total therapeutic efficiency of the observation group was higher than that of the control group, and the difference was statistically significant (P<0.05). Conclusion Early application of salvianolate in patients with cerebral infarction can effectively improve neurological function and has good curative effect.